NCT00257816 2018-02-05
Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma
University of California, Irvine
Phase 2 Completed
Clinical Trials
11 trialsNCT00287911 2017-12-02
Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer
Masonic Cancer Center, University of Minnesota
Phase 1 Completed
NCT02348398 2016-08-16
Phase II Study of Pazopanib and Topotecan in Cervical Cancer
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT00807079 2014-10-29
Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer
ARCAGY/ GINECO GROUP
Phase 1/2 Completed
NCT00548418 2014-08-01
Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer
Washington University School of Medicine
Phase 2 Completed
NCT00523432 2013-09-05
A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies
University of Chicago
Phase 1 Completed
NCT00842452 2013-04-05
Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00320983 2010-01-07
Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer
University of New Mexico
Phase 1 Completed
NCT00315861 2009-01-23
Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
SCRI Development Innovations, LLC
Phase 1 Completed
NCT00826891 2009-01-22
Study of Cisplatin in Cervical Cancer Stage IVB
Chinese Anti-Cancer Association
Phase 2 Unknown
NCT00322920 2008-02-15
Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer
University of Alabama at Birmingham
Phase 1 Terminated